Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS".
作者信息
Anastasilakis Athanasios D, Pepe Jessica, Napoli Nicola, Palermo Andrea, Magopoulos Christos, Khan Aliya A, Zillikens M Carola, Body Jean-Jacques
机构信息
Department of Endocrinology, 424 General Military Hospital, Thessaloniki 56429, Greece.
Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
出版信息
J Clin Endocrinol Metab. 2022 May 17;107(6):e2651-e2652. doi: 10.1210/clinem/dgac111.
Abstract
摘要
相似文献
1
Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS".对田口致编辑信的回复：“颌骨骨坏死与良性和恶性疾病中的抗吸收剂：欧洲钙化组织学会组织的批判性综述”
J Clin Endocrinol Metab. 2022 May 17;107(6):e2651-e2652. doi: 10.1210/clinem/dgac111.
2
Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS".来自田口的致编辑信：“颌骨坏死与良性及恶性疾病中的抗吸收剂：欧洲钙化组织学会组织的一项批判性综述”
J Clin Endocrinol Metab. 2022 May 17;107(6):e2646. doi: 10.1210/clinem/dgac109.
3
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.颌骨骨坏死与良性及恶性疾病中的抗吸收药物：由 ECTS 组织的批判性回顾。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
4
Antiresorptive drug-related osteonecrosis of the jaw.抗吸收药物相关的颌骨坏死
Dent Clin North Am. 2014 Apr;58(2):369-84. doi: 10.1016/j.cden.2013.12.006.
5
Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?地诺单抗，双膦酸盐的替代品但也与颌骨坏死相关——风险是什么？
Dent Update. 2015 Jun;42(5):436-8, 440. doi: 10.12968/denu.2015.42.5.436.
6
[Osteonecrosis of the jaw].[颌骨骨坏死]
Endokrynol Pol. 2011;62 Suppl 3:4-9.
7
Osteonecrosis of the Jaw.颌骨骨坏死
J Clin Densitom. 2017 Jan-Mar;20(1):1-2. doi: 10.1016/j.jocd.2016.12.002.
8
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.药物性颌骨坏死的发生率及其相关危险因素。
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9.
9
Antimicrobial peptide gene expression in medication-related osteonecrosis of the jaw.抗菌肽基因在药物相关性颌骨坏死中的表达
Pathol Res Pract. 2020 Dec;216(12):153245. doi: 10.1016/j.prp.2020.153245. Epub 2020 Oct 9.
10
Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.抗吸收药物对颌骨骨转换的影响：地诺单抗与双膦酸盐的比较。
Br J Oral Maxillofac Surg. 2014 Apr;52(4):308-13. doi: 10.1016/j.bjoms.2014.01.021. Epub 2014 Feb 26.
引用本文的文献
1
Evaluating the Anti-Osteoporotic Potential of Mediterranean Medicinal Plants: A Review of Current Evidence.评估地中海药用植物的抗骨质疏松潜力：当前证据综述
Pharmaceuticals (Basel). 2024 Oct 8;17(10):1341. doi: 10.3390/ph17101341.
本文引用的文献
1
Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS".来自田口的致编辑信：“颌骨坏死与良性及恶性疾病中的抗吸收剂：欧洲钙化组织学会组织的一项批判性综述”
J Clin Endocrinol Metab. 2022 May 17;107(6):e2646. doi: 10.1210/clinem/dgac109.
2
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.颌骨骨坏死与良性及恶性疾病中的抗吸收药物：由 ECTS 组织的批判性回顾。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
3
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations.绝经后骨质疏松症合并其他代谢性疾病：治疗注意事项。
Maturitas. 2021 May;147:19-25. doi: 10.1016/j.maturitas.2021.02.007. Epub 2021 Mar 1.
4
Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.阿仑膦酸钠与雷洛昔芬治疗骨质疏松症女性的比较安全性和有效性。
Sci Rep. 2020 Jul 6;10(1):11115. doi: 10.1038/s41598-020-68037-8.
5
Lower bone mass is associated with subclinical atherosclerosis, endothelial dysfunction and carotid thickness in the very elderly.老年人骨量低与亚临床动脉粥样硬化、内皮功能障碍和颈动脉厚度有关。
Atherosclerosis. 2020 Jan;292:70-74. doi: 10.1016/j.atherosclerosis.2019.11.007. Epub 2019 Nov 14.
6
Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population.台湾骨质疏松症人群中颌骨坏死的发病率及风险
Osteoporos Int. 2014 May;25(5):1503-11. doi: 10.1007/s00198-014-2624-6. Epub 2014 Feb 11.
7
Osteoporosis--a risk factor for cardiovascular disease?骨质疏松症——心血管疾病的危险因素？
Nat Rev Rheumatol. 2012 Oct;8(10):587-98. doi: 10.1038/nrrheum.2012.120. Epub 2012 Aug 14.
Zotero 插件